Public Meeting: Postmarketing Requirements for the Class-Wide Extended-Rele...

Actions and Detail Panel

Sales Ended

Event Information

Location

Location

FDA White Oak Campus

10903 New Hampshire Ave.

Building 31, Room 1503 B+C

Silver Spring, MD 20993

View Map

Event description

Description

The Food and Drug Administration (FDA) is announcing a public meeting to obtain stakeholder input on the design and conduct of the postmarketing requirements (PMRs) for the class-wide extended-release/long-acting (ER/LA) opioid analgesic drug products to further assess the serious risks of misuse, abuse, hyperalgesia, addiction, overdose, and death associated with their long-term use.

The public meeting will be held on May 19 and 20, 2014, from 8 a.m. to 5 p.m on FDA's White Oak Campus. For more information, visit www.fda.gov/Drugs/NewsEvents/ucm384489.htm.

Location

FDA White Oak Campus

10903 New Hampshire Ave.

Building 31, Room 1503 B+C

Silver Spring, MD 20993

View Map

Organizer United States Food and Drug Administration

Organizer of Public Meeting: Postmarketing Requirements for the Class-Wide Extended-Release/Long-Acting Opioid Analgesics

Save This Event

Event Saved